Search results
Results from the WOW.Com Content Network
Notes: Sample sizes (n) include placebo recipients, which were about half of patients. "Global index" is defined for each woman as the time to earliest diagnosis for coronary heart disease , stroke , pulmonary embolism , breast cancer , colorectal cancer , endometrial cancer (estrogen plus progestogen group only), hip fractures , and death from ...
A package insert from 1970, with Ovrette brand contraception pills. A package insert is a document included in the package of a medication that provides information about that drug and its use. For prescription medications, the insert is technical, providing information for medical professionals about how to prescribe the drug.
In 1984, its extended-release formulation of morphine, MS Contin was released. OxyContin was released in 1996 after Curtis Wright, an employee of the Food and Drug Administration [23] approved its use on a 12-hour dosage cycle. [24] Around the time of OxyContin's release, the American Pain Society introduced its "pain as fifth vital sign" campaign.
The tables below contain a sample list of benzodiazepines and benzodiazepine analogs that are commonly prescribed, with their basic pharmacological characteristics, such as half-life and equivalent doses to other benzodiazepines, also listed, along with their trade names and primary uses.
The details of label includes the name of preparation, quantity of drugs, instructions for patients, patient's name and the date of dispensing Drug labelling , also referred to as prescription labelling , is a written, printed or graphic matter upon any drugs or any of its container, or accompanying such a drug.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
An auxiliary label (also called cautionary and advisory label or prescription drug warning label) is a label added on to a dispensed medication package by a pharmacist in addition to the usual prescription label. These labels are intended to provide supplementary information regarding the safe administration, use, and storage of the medication. [1]
Euthyroid populations demonstrate increased CV risk at clinical doses. Hypothyroid agents should not be used in combination with sympathomimetic agents including: stimulants, and diet pills, due to increased CV risks.